Rare diseases
Investigational molecules
Locations
Rue Docteur-Yersin 10, 1110
Clinical research in recurrent or metastatic squamous cell carcinoma of the head and neck with an emphasis on PD-L1-positive disease and first-line immunotherapy combinations.
The focus includes combination immuno-oncology strategies for advanced head and neck malignancies.
Incyte Biosciences International S.a.r.l. runs clinical trials in conditions such as Acute myeloid leukaemia, Acute leukaemia, Chronic myeloid leukaemia, Myeloid leukaemia, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study on Ponatinib for Treating Recurrent or Refractory Leukemias and Solid Tumors in Children
BelgiumStudy of Retifanlimab, INCAGN02385, and INCAGN02390 for First-Line Treatment in Patients with PD-L1 Positive Recurrent/Metastatic Head and Neck Cancer
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
